Ex­elix­is drug fails PhI­II lung can­cer tri­al with Cabome­tyx and Tecen­triq com­bo

3 years ago
R&D

WIB22: Chas­ing af­ter ever-evolv­ing sci­ence takes a drug hunter across the pond

3 years ago
People
Special

Scoop: Stephen Squin­to’s Yale spin­out is rais­ing a Se­ries B for ge­net­ic med­i­cines

3 years ago
Financing
Startups

Bio­gen vet jumps to CSO at Third Rock Treg biotech; Karuna CEO is step­ping down, but this is­n't good­bye

3 years ago
Peer Review

Au­to­lus tips its hand, bags $220M as CAR-T show­down with Gilead looms

3 years ago
Financing
R&D

Scoop: On­copep­tides CEO ‘lean­ing to­ward’ giv­ing in to FDA with­draw­al re­quest amid ‘piss­ing con­test’ with ...

3 years ago
FDA+

Sen­ate Fi­nance chair goes af­ter Am­gen again on US tax­es, ask­ing for pay­ment specifics

3 years ago
Pharma
Law

Ready for take­off: ARPA-H in­tros plan to at­tract project in­vestors, com­mer­cial­ize prod­ucts

3 years ago
R&D

WIB22: Suma Kr­ish­nan co-found­ed a com­pa­ny to de­vel­op a treat­ment for ‘the worst dis­ease you’ve nev­er heard of’

3 years ago
People
Special

FDA com­mis­sion­er on drug ap­provals: The prob­lem is­n't in­no­va­tion or speed

3 years ago
FDA+

Take­da nabs dengue vac­cine ap­proval in Eu­rope, as trav­el, cli­mate change con­tribute to rise in cas­es

3 years ago
Pharma
Marketing

FDA au­tho­rizes bi­va­lent Covid boost­ers for chil­dren 6 months and up

3 years ago
Pharma
FDA+

Pub­li­cis for­goes light­heart­ed hol­i­day mes­sage for more se­ri­ous HPV warn­ing with celebri­ty guest

3 years ago
Pharma
Marketing

Nashville-based CD­MO nets a $65M Se­ries B to ex­pand fa­cil­i­ty and ca­pa­bil­i­ties

3 years ago
Financing
Pharma

Man­u­fac­tur­ing roundup: Mil­li­pore­Sig­ma ac­quires biore­ac­tor mak­er; Kite, Dai­ichi Sankyo change Yescar­ta agree­ment

3 years ago
Manufacturing

QC vi­o­la­tions raised by FDA at an­oth­er Au­robindo site

3 years ago
Pharma
FDA+

CNS biotech's stock dives — again — as lead can­di­date fails sec­ond PhI­II test

3 years ago
R&D

WIB22: She re­shaped mi­graine sci­ence and led key tri­als for new drugs, but Sheena Au­ro­ra isn’t done

3 years ago
People
Special

Near­ly out of cash, a for­mer Sarep­ta part­ner asks French courts to over­see re­struc­tur­ing

3 years ago
Financing
R&D

Sen­sei and In­stil Bio let go large chunks of work­forces, shift pipelines

3 years ago
People

FDA halts im­ports of sev­er­al Sun Phar­ma drugs made in In­dia due to out­stand­ing qual­i­ty is­sues

3 years ago
Pharma
FDA+

Scoop: Gilead ter­mi­nates ear­ly-stage FLT3 tri­al in sol­id tu­mors

3 years ago
R&D

As­traZeneca’s Su­san Gal­braith high­lights twin wins for the can­cer drug pipeline at SABCS, as oral SERD ex­cels

3 years ago
R&D

No­var­tis' ip­ta­co­pan meets PhI­II test in fight against rare blood dis­ease

3 years ago
R&D
Pharma
First page Previous page 417418419420421422423 Next page Last page
A service from the Financial Times